IBI3016

DRUG2 trials

Sponsors

Innovent Biologics (Suzhou) Co. Ltd.

Conditions

Hypertension

Phase 1

Study of IBI3016 in People With Mild or Moderate Hypertension Patients

Not yet recruitingNCT07556796

Innovent Biologics (Suzhou) Co. Ltd.Hypertension

Start: 2026-05-15End: 2027-10-16Target: 30Updated: 2026-04-29

Phase 2

A Dose Finding Study of IBI3016 in Mild to Moderate Hypertensive Patients

Not yet recruitingNCT07352969

Innovent Biologics (Suzhou) Co. Ltd.Hypertension

Start: 2026-02-06End: 2029-03-27Target: 352Updated: 2026-01-20